神経リハビリテーション機器の市場規模、シェア、動向分析レポート:製品別(BCI、ウェアラブル機器、ニューロロボティクス)、治療領域別(脳卒中、パーキンソン病、脳性麻痺)、地域別、セグメント別予測、2024年~2030年Neurorehabilitation Devices Market Size, Share & Trends Analysis Report By Product (BCI, Wearable Devices, Neurorobotics), By Therapy Area (Stroke, Parkinsons Disease, Cerebral Palsy), By Region, And Segment Forecasts, 2024 - 2030 神経リハビリテーション機器市場の成長と動向 Grand View Research, Inc.の最新レポートによると、世界の神経リハビリテーション機器市場規模は、2024年から2030年にかけて13.9%のCAGRを記録し、2030年には49.... もっと見る
本レポートは受注生産のため、ご納品のお時間をいただく場合がございます。
サマリー神経リハビリテーション機器市場の成長と動向Grand View Research, Inc.の最新レポートによると、世界の神経リハビリテーション機器市場規模は、2024年から2030年にかけて13.9%のCAGRを記録し、2030年には49.8億米ドルに達すると予測されている。新規製品発売のための研究開発重視の高まり、患者の転帰を向上させる革新的技術&デバイスの生産、ブレイン・コンピュータ・インターフェイス(BCI)や神経刺激デバイスを含む神経補綴デバイスの製造などの医療技術の進歩、遠隔医療&遠隔リハビリテーション・ソリューションの採用増加などが、業界成長の原動力となっている。患者の転帰を改善する最先端のツールや技術の開発も市場成長の原動力となっている。医療費が高騰すれば、最先端の神経リハビリ機器を購入できる財源が増える。 医療予算が潤沢な企業では、ニューロリハビリテーション分野の研究開発に資金を確保できるかもしれない。その結果、神経リハビリテーションのための斬新で改良されたツールが開発されるかもしれない。例えば、2023年3月、インテリジェントなリハビリテーション・ソリューションを提供する中国企業SiYi Intelligenceは、Tao CapitalとChengdu Bio-town Equity Investment Fundの参加を得て、シリーズA投資ラウンドで150億米ドルを調達したことを最近明らかにした。同企業はこの資金で、神経リハビリ・ソリューション統合の研究開発を進め、新たなデジタル・リハビリ・サービス・プラットフォームを構築するつもりだった。医療機器メーカー、学術機関、医療プロバイダーなどの主要な業界関係者が、製品開発のための戦略的提携やパートナーシップに関与している。 研究開発資源は、共同作業を通じて組み合わせることができ、より迅速な発明と、より効率的な製品の開発を促進する。バーチャルリアリティ(VR)やARのような技術は、神経リハビリテーションに利用されている。VRやARのような技術は、運動能力や認知能力の回復をサポートする刺激的な活動に患者が参加できるような、魅力的な治療環境をデザインすることができる。セラピストはVRやARを通じてリアルタイムのフィードバックを受けることができる。例えば、2023年4月、VHA(退役軍人健康管理局)のOffice of Healthcare Innovation and Learningと、最先端治療を専門とする世界的なヘルスケア企業であるPenumbra, Inc.は、VRベースのリハビリテーション・ヘルスケア・ソリューションのテスト、共同開発、導入に向けて協力することを発表した。 神経リハビリ機器市場レポートハイライト - 2023年には、ロボット工学と神経技術の継続的な進歩により、より高度で効果的な神経ロボティクスデバイスが開発されたため、神経ロボティクス分野が36.0%のシェアを占め、市場を支配した - 脳卒中治療分野セグメントは、2023年に44.3%の最大の収益シェアを占めた。在宅での神経リハビリテーション技術の利用が普及している。 - 遠隔モニタリングや遠隔リハビリテーション・プログラムにより、脳卒中患者が自宅にいながら回復を続けられるようになり、リハビリテーション・サービスの利用可能性が高まっている。 - 2023年の世界市場シェアは39.08%で北米が圧倒的。この地域市場は、新興企業だけでなく少数の既存企業の存在により競争が激しい。 - これらの企業は、製品の革新、合併、買収、提携を通じて、より高い業界シェアを獲得しようと努力している。 目次Table of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Product 1.1.2. Therapy area 1.1.3. Regional scope 1.1.4. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.3.5.1. Data for primary interviews in North America 1.3.5.2. Data for primary interviews in Europe 1.3.5.3. Data for primary interviews in Asia Pacific 1.3.5.4. Data for primary interviews in Latin America 1.3.5.5. Data for Primary interviews in MEA 1.4. Information or Data Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis (Model 1) 1.6.1.1. Approach 1: Commodity flow approach 1.6.2. Volume price analysis (Model 2) 1.6.2.1. Approach 2: Volume price analysis 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives 1.9.1. Objective 1 1.9.2. Objective 2 Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Product outlook 2.2.2. Therapy area outlook 2.2.3. Regional outlook 2.3. Competitive Insights Chapter 3. Neurorehabilitation Devices Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Industry Value Chain Analysis 3.3.1. Reimbursement framework 3.4. Market Dynamics 3.4.1. Market driver analysis 3.4.1.1. Increasing incidence of neurological diseases 3.4.1.2. Technological advancements 3.4.1.3. Increasing clinical studies for the neurorehabilitation devices product development 3.4.2. Market restraint analysis 3.4.2.1. High cost of devices 3.4.2.2. Complex regulatory framework 3.5. Neurorehabilitation Devices Market Analysis Tools 3.5.1. Industry Analysis - Porter’s 3.5.1.1. Supplier power 3.5.1.2. Buyer power 3.5.1.3. Substitution threat 3.5.1.4. Threat of new entrant 3.5.1.5. Competitive rivalry 3.5.2. PESTEL Analysis 3.5.2.1. Political landscape 3.5.2.2. Technological landscape 3.5.2.3. Economic landscape 3.5.3. Major Deals & Strategic Alliances Analysis 3.5.4. Market Entry Strategies Chapter 4. Neurorehabilitation Devices Market: Product Estimates & Trend Analysis 4.1. Definitions and Scope 4.1.1. Neurorobotics 4.1.2. Brain-Computer Interface 4.1.3. Wearable Devices 4.1.4. Non-Invasive Stimulators 4.1.5. Others 4.2. Product Market Share, 2023 & 2030 4.3. Segment Dashboard 4.4. Global Neurorehabilitation Devices Market by Product Outlook 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 4.5.1. Neurorobotics 4.5.1.1. Neurorobotics market estimates and forecast 2018 to 2030 (USD Million) 4.5.2. Brain-Computer Interface 4.5.2.1. Brain-computer interface market estimates and forecast 2018 to 2030 (USD Million) 4.5.3. Wearable Devices 4.5.3.1. Wearable devices market estimates and forecast 2018 to 2030 (USD Million) 4.5.4. Non-Invasive Stimulators 4.5.4.1. Non-invasive stimulators market estimates and forecast 2018 to 2030 (USD Million) 4.5.5. Others 4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million) Chapter 5. Neurorehabilitation Devices Market: Therapy Area Estimates & Trend Analysis 5.1. Definitions and Scope 5.1.1. Stroke 5.1.2. Parkinson’s Disease 5.1.3. Multiple Sclerosis 5.1.4. Cerebral Palsy 5.1.5. Others 5.2. Therapy area Market Share, 2023 & 2030 5.3. Segment Dashboard 5.4. Neurorehabilitation Devices Market by Therapy Area Outlook 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 5.5.1. Stroke 5.5.1.1. Stroke market estimates and forecast 2018 to 2030 (USD Million) 5.5.2. Parkinson’s Disease 5.5.2.1. Parkinson’s disease market estimates and forecast 2018 to 2030 (USD Million) 5.5.3. Multiple Sclerosis 5.5.3.1. Multiple sclerosis market estimates and forecast 2018 to 2030 (USD Million) 5.5.4. Cerebral Palsy 5.5.4.1. Cerebral palsy market estimates and forecast 2018 to 2030 (USD Million) 5.5.5. Others 5.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million) Chapter 6. Neurorehabilitation Devices Market: Regional Estimates & Trend Analysis 6.1. Regional market share analysis, 2023 & 2030 6.2. Regional Market Dashboard 6.3. Global Regional Market Snapshot 6.4. Regional Market Share and Leading Players, 2023 6.4.1. North America 6.4.2. Europe 6.4.3. Asia Pacific 6.4.4. Latin America 6.4.5. Middle East and Africa 6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030: 6.6. North America 6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 6.6.2. U.S. 6.6.2.1. Key country dynamics 6.6.2.2. Competitive Scenario 6.6.2.3. Regulatory framework 6.6.2.4. Reimbursement scenario 6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030 6.6.3. Canada 6.6.3.1. Key country dynamics 6.6.3.2. Competitive Scenario 6.6.3.3. Regulatory framework 6.6.3.4. Reimbursement scenario 6.6.3.5. Canada market estimates and forecasts, 2018 - 2030 6.7. Europe 6.7.1. UK 6.7.1.1. Key country dynamics 6.7.1.2. Competitive Scenario 6.7.1.3. Regulatory framework 6.7.1.4. Reimbursement scenario 6.7.1.5. UK market estimates and forecasts, 2018 - 2030 6.7.2. Germany 6.7.2.1. Key country dynamics 6.7.2.2. Competitive Scenario 6.7.2.3. Regulatory framework 6.7.2.4. Reimbursement scenario 6.7.2.5. Germany market estimates and forecasts, 2018 - 2030 6.7.3. France 6.7.3.1. Key country dynamics 6.7.3.2. Competitive Scenario 6.7.3.3. Regulatory framework 6.7.3.4. Reimbursement scenario 6.7.3.5. France market estimates and forecasts, 2018 - 2030 6.7.4. Italy 6.7.4.1. Key country dynamics 6.7.4.2. Competitive Scenario 6.7.4.3. Regulatory framework 6.7.4.4. Reimbursement scenario 6.7.4.5. Italy market estimates and forecasts, 2018 - 2030 6.7.5. Spain 6.7.5.1. Key country dynamics 6.7.5.2. Competitive Scenario 6.7.5.3. Regulatory framework 6.7.5.4. Reimbursement scenario 6.7.5.5. Spain market estimates and forecasts, 2018 - 2030 6.7.6. Denmark 6.7.6.1. Key country dynamics 6.7.6.2. Competitive Scenario 6.7.6.3. Regulatory framework 6.7.6.4. Reimbursement scenario 6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030 6.7.7. Sweden 6.7.7.1. Key country dynamics 6.7.7.2. Competitive Scenario 6.7.7.3. Regulatory framework 6.7.7.4. Reimbursement scenario 6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030 6.7.8. Norway 6.7.8.1. Key country dynamics 6.7.8.2. Competitive Scenario 6.7.8.3. Regulatory framework 6.7.8.4. Reimbursement scenario 6.7.8.5. Norway market estimates and forecasts, 2018 - 2030 6.8. Asia Pacific 6.8.1. Japan 6.8.1.1. Key country dynamics 6.8.1.2. Competitive Scenario 6.8.1.3. Regulatory framework 6.8.1.4. Reimbursement scenario 6.8.1.5. Japan market estimates and forecasts, 2018 - 2030 6.8.2. India 6.8.2.1. Key country dynamics 6.8.2.2. Competitive Scenario 6.8.2.3. Regulatory framework 6.8.2.4. Reimbursement scenario 6.8.2.5. India market estimates and forecasts, 2018 - 2030 6.8.3. China 6.8.3.1. Key country dynamics 6.8.3.2. Competitive Scenario 6.8.3.3. Regulatory framework 6.8.3.4. Reimbursement scenario 6.8.3.5. China market estimates and forecasts, 2018 - 2030 6.8.4. South Korea 6.8.4.1. Key country dynamics 6.8.4.2. Competitive Scenario 6.8.4.3. Regulatory framework 6.8.4.4. Reimbursement scenario 6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030 6.8.5. Australia 6.8.5.1. Key country dynamics 6.8.5.2. Competitive Scenario 6.8.5.3. Regulatory framework 6.8.5.4. Reimbursement scenario 6.8.5.5. Australia market estimates and forecasts, 2018 - 2030 6.8.6. Thailand 6.8.6.1. Key country dynamics 6.8.6.2. Competitive Scenario 6.8.6.3. Regulatory framework 6.8.6.4. Reimbursement scenario 6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030 6.9. Latin America 6.9.1. Brazil 6.9.1.1. Key country dynamics 6.9.1.2. Competitive Scenario 6.9.1.3. Regulatory framework 6.9.1.4. Reimbursement scenario 6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030 6.9.2. Mexico 6.9.2.1. Key country dynamics 6.9.2.2. Competitive Scenario 6.9.2.3. Regulatory framework 6.9.2.4. Reimbursement scenario 6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030 6.9.3. Argentina 6.9.3.1. Key country dynamics 6.9.3.2. Competitive Scenario 6.9.3.3. Regulatory framework 6.9.3.4. Reimbursement scenario 6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030 6.10. MEA 6.10.1. South Africa 6.10.1.1. Key country dynamics 6.10.1.2. Competitive Scenario 6.10.1.3. Regulatory framework 6.10.1.4. Reimbursement scenario 6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030 6.10.2. Saudi Arabia 6.10.2.1. Key country dynamics 6.10.2.2. Competitive Scenario 6.10.2.3. Regulatory framework 6.10.2.4. Reimbursement scenario 6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 6.10.3. UAE 6.10.3.1. Key country dynamics 6.10.3.2. Competitive Scenario 6.10.3.3. Regulatory framework 6.10.3.4. Reimbursement scenario 6.10.3.5. UAE market estimates and forecasts, 2018 - 2030 6.10.4. Kuwait 6.10.4.1. Key country dynamics 6.10.4.2. Competitive Scenario 6.10.4.3. Regulatory framework 6.10.4.4. Reimbursement scenario 6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030 Chapter 7. Competitive Landscape 7.1. Recent Developments & Impact Analysis, By Key Market Participants 7.2. Company/Competition Categorization 7.2.1. Innovators 7.3. Vendor Landscape 7.3.1. List of key distributors and channel partners 7.3.2. Key customers 7.3.3. Key company market share analysis, 2023 7.3.4. Bioventus 7.3.4.1. Company overview 7.3.4.2. Financial performance 7.3.4.3. Product benchmarking 7.3.4.4. Strategic initiatives 7.3.5. Ectron 7.3.5.1. Company overview 7.3.5.2. Financial performance 7.3.5.3. Product benchmarking 7.3.5.4. Strategic initiatives 7.3.6. Hocoma 7.3.6.1. Company overview 7.3.6.2. Financial performance 7.3.6.3. Product benchmarking 7.3.6.4. Strategic initiatives 7.3.7. Medtronic 7.3.7.1. Company overview 7.3.7.2. Financial performance 7.3.7.3. Product benchmarking 7.3.7.4. Strategic initiatives 7.3.8. Tyromotion Inc. 7.3.8.1. Company overview 7.3.8.2. Financial performance 7.3.8.3. Product benchmarking 7.3.8.4. Strategic initiatives 7.3.9. Abbott 7.3.9.1. Company overview 7.3.9.2. Financial performance 7.3.9.3. Product benchmarking 7.3.9.4. Strategic initiatives 7.3.10. Biometrics Ltd 7.3.10.1. Company overview 7.3.10.2. Financial performance 7.3.10.3. Product benchmarking 7.3.10.4. Strategic initiatives 7.3.11. Bionik Laboratories Corp. (BNKL) 7.3.11.1. Company overview 7.3.11.2. Financial performance 7.3.11.3. Product benchmarking 7.3.11.4. Strategic initiatives 7.3.12. BioXtreme Ltd. 7.3.12.1. Company overview 7.3.12.2. Financial performance 7.3.12.3. Product benchmarking 7.3.12.4. Strategic initiatives 7.3.13. Ekso Bionics 7.3.13.1. Company overview 7.3.13.2. Financial performance 7.3.13.3. Product benchmarking 7.3.13.4. Strategic initiatives 7.3.14. Saebo, Inc 7.3.14.1. Company overview 7.3.14.2. Financial performance 7.3.14.3. Product benchmarking 7.3.14.4. Strategic initiatives 7.3.15. Kinova inc. 7.3.15.1. Company overview 7.3.15.2. Financial performance 7.3.15.3. Product benchmarking 7.3.15.4. Strategic initiatives 7.3.16. Kinestica 7.3.16.1. Company overview 7.3.16.2. Financial performance 7.3.16.3. Product benchmarking 7.3.16.4. Strategic initiatives
SummaryNeurorehabilitation Devices Market Growth & Trends Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Product 1.1.2. Therapy area 1.1.3. Regional scope 1.1.4. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.3.5.1. Data for primary interviews in North America 1.3.5.2. Data for primary interviews in Europe 1.3.5.3. Data for primary interviews in Asia Pacific 1.3.5.4. Data for primary interviews in Latin America 1.3.5.5. Data for Primary interviews in MEA 1.4. Information or Data Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis (Model 1) 1.6.1.1. Approach 1: Commodity flow approach 1.6.2. Volume price analysis (Model 2) 1.6.2.1. Approach 2: Volume price analysis 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives 1.9.1. Objective 1 1.9.2. Objective 2 Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Product outlook 2.2.2. Therapy area outlook 2.2.3. Regional outlook 2.3. Competitive Insights Chapter 3. Neurorehabilitation Devices Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Industry Value Chain Analysis 3.3.1. Reimbursement framework 3.4. Market Dynamics 3.4.1. Market driver analysis 3.4.1.1. Increasing incidence of neurological diseases 3.4.1.2. Technological advancements 3.4.1.3. Increasing clinical studies for the neurorehabilitation devices product development 3.4.2. Market restraint analysis 3.4.2.1. High cost of devices 3.4.2.2. Complex regulatory framework 3.5. Neurorehabilitation Devices Market Analysis Tools 3.5.1. Industry Analysis - Porter’s 3.5.1.1. Supplier power 3.5.1.2. Buyer power 3.5.1.3. Substitution threat 3.5.1.4. Threat of new entrant 3.5.1.5. Competitive rivalry 3.5.2. PESTEL Analysis 3.5.2.1. Political landscape 3.5.2.2. Technological landscape 3.5.2.3. Economic landscape 3.5.3. Major Deals & Strategic Alliances Analysis 3.5.4. Market Entry Strategies Chapter 4. Neurorehabilitation Devices Market: Product Estimates & Trend Analysis 4.1. Definitions and Scope 4.1.1. Neurorobotics 4.1.2. Brain-Computer Interface 4.1.3. Wearable Devices 4.1.4. Non-Invasive Stimulators 4.1.5. Others 4.2. Product Market Share, 2023 & 2030 4.3. Segment Dashboard 4.4. Global Neurorehabilitation Devices Market by Product Outlook 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 4.5.1. Neurorobotics 4.5.1.1. Neurorobotics market estimates and forecast 2018 to 2030 (USD Million) 4.5.2. Brain-Computer Interface 4.5.2.1. Brain-computer interface market estimates and forecast 2018 to 2030 (USD Million) 4.5.3. Wearable Devices 4.5.3.1. Wearable devices market estimates and forecast 2018 to 2030 (USD Million) 4.5.4. Non-Invasive Stimulators 4.5.4.1. Non-invasive stimulators market estimates and forecast 2018 to 2030 (USD Million) 4.5.5. Others 4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million) Chapter 5. Neurorehabilitation Devices Market: Therapy Area Estimates & Trend Analysis 5.1. Definitions and Scope 5.1.1. Stroke 5.1.2. Parkinson’s Disease 5.1.3. Multiple Sclerosis 5.1.4. Cerebral Palsy 5.1.5. Others 5.2. Therapy area Market Share, 2023 & 2030 5.3. Segment Dashboard 5.4. Neurorehabilitation Devices Market by Therapy Area Outlook 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 5.5.1. Stroke 5.5.1.1. Stroke market estimates and forecast 2018 to 2030 (USD Million) 5.5.2. Parkinson’s Disease 5.5.2.1. Parkinson’s disease market estimates and forecast 2018 to 2030 (USD Million) 5.5.3. Multiple Sclerosis 5.5.3.1. Multiple sclerosis market estimates and forecast 2018 to 2030 (USD Million) 5.5.4. Cerebral Palsy 5.5.4.1. Cerebral palsy market estimates and forecast 2018 to 2030 (USD Million) 5.5.5. Others 5.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million) Chapter 6. Neurorehabilitation Devices Market: Regional Estimates & Trend Analysis 6.1. Regional market share analysis, 2023 & 2030 6.2. Regional Market Dashboard 6.3. Global Regional Market Snapshot 6.4. Regional Market Share and Leading Players, 2023 6.4.1. North America 6.4.2. Europe 6.4.3. Asia Pacific 6.4.4. Latin America 6.4.5. Middle East and Africa 6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030: 6.6. North America 6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 6.6.2. U.S. 6.6.2.1. Key country dynamics 6.6.2.2. Competitive Scenario 6.6.2.3. Regulatory framework 6.6.2.4. Reimbursement scenario 6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030 6.6.3. Canada 6.6.3.1. Key country dynamics 6.6.3.2. Competitive Scenario 6.6.3.3. Regulatory framework 6.6.3.4. Reimbursement scenario 6.6.3.5. Canada market estimates and forecasts, 2018 - 2030 6.7. Europe 6.7.1. UK 6.7.1.1. Key country dynamics 6.7.1.2. Competitive Scenario 6.7.1.3. Regulatory framework 6.7.1.4. Reimbursement scenario 6.7.1.5. UK market estimates and forecasts, 2018 - 2030 6.7.2. Germany 6.7.2.1. Key country dynamics 6.7.2.2. Competitive Scenario 6.7.2.3. Regulatory framework 6.7.2.4. Reimbursement scenario 6.7.2.5. Germany market estimates and forecasts, 2018 - 2030 6.7.3. France 6.7.3.1. Key country dynamics 6.7.3.2. Competitive Scenario 6.7.3.3. Regulatory framework 6.7.3.4. Reimbursement scenario 6.7.3.5. France market estimates and forecasts, 2018 - 2030 6.7.4. Italy 6.7.4.1. Key country dynamics 6.7.4.2. Competitive Scenario 6.7.4.3. Regulatory framework 6.7.4.4. Reimbursement scenario 6.7.4.5. Italy market estimates and forecasts, 2018 - 2030 6.7.5. Spain 6.7.5.1. Key country dynamics 6.7.5.2. Competitive Scenario 6.7.5.3. Regulatory framework 6.7.5.4. Reimbursement scenario 6.7.5.5. Spain market estimates and forecasts, 2018 - 2030 6.7.6. Denmark 6.7.6.1. Key country dynamics 6.7.6.2. Competitive Scenario 6.7.6.3. Regulatory framework 6.7.6.4. Reimbursement scenario 6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030 6.7.7. Sweden 6.7.7.1. Key country dynamics 6.7.7.2. Competitive Scenario 6.7.7.3. Regulatory framework 6.7.7.4. Reimbursement scenario 6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030 6.7.8. Norway 6.7.8.1. Key country dynamics 6.7.8.2. Competitive Scenario 6.7.8.3. Regulatory framework 6.7.8.4. Reimbursement scenario 6.7.8.5. Norway market estimates and forecasts, 2018 - 2030 6.8. Asia Pacific 6.8.1. Japan 6.8.1.1. Key country dynamics 6.8.1.2. Competitive Scenario 6.8.1.3. Regulatory framework 6.8.1.4. Reimbursement scenario 6.8.1.5. Japan market estimates and forecasts, 2018 - 2030 6.8.2. India 6.8.2.1. Key country dynamics 6.8.2.2. Competitive Scenario 6.8.2.3. Regulatory framework 6.8.2.4. Reimbursement scenario 6.8.2.5. India market estimates and forecasts, 2018 - 2030 6.8.3. China 6.8.3.1. Key country dynamics 6.8.3.2. Competitive Scenario 6.8.3.3. Regulatory framework 6.8.3.4. Reimbursement scenario 6.8.3.5. China market estimates and forecasts, 2018 - 2030 6.8.4. South Korea 6.8.4.1. Key country dynamics 6.8.4.2. Competitive Scenario 6.8.4.3. Regulatory framework 6.8.4.4. Reimbursement scenario 6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030 6.8.5. Australia 6.8.5.1. Key country dynamics 6.8.5.2. Competitive Scenario 6.8.5.3. Regulatory framework 6.8.5.4. Reimbursement scenario 6.8.5.5. Australia market estimates and forecasts, 2018 - 2030 6.8.6. Thailand 6.8.6.1. Key country dynamics 6.8.6.2. Competitive Scenario 6.8.6.3. Regulatory framework 6.8.6.4. Reimbursement scenario 6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030 6.9. Latin America 6.9.1. Brazil 6.9.1.1. Key country dynamics 6.9.1.2. Competitive Scenario 6.9.1.3. Regulatory framework 6.9.1.4. Reimbursement scenario 6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030 6.9.2. Mexico 6.9.2.1. Key country dynamics 6.9.2.2. Competitive Scenario 6.9.2.3. Regulatory framework 6.9.2.4. Reimbursement scenario 6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030 6.9.3. Argentina 6.9.3.1. Key country dynamics 6.9.3.2. Competitive Scenario 6.9.3.3. Regulatory framework 6.9.3.4. Reimbursement scenario 6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030 6.10. MEA 6.10.1. South Africa 6.10.1.1. Key country dynamics 6.10.1.2. Competitive Scenario 6.10.1.3. Regulatory framework 6.10.1.4. Reimbursement scenario 6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030 6.10.2. Saudi Arabia 6.10.2.1. Key country dynamics 6.10.2.2. Competitive Scenario 6.10.2.3. Regulatory framework 6.10.2.4. Reimbursement scenario 6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 6.10.3. UAE 6.10.3.1. Key country dynamics 6.10.3.2. Competitive Scenario 6.10.3.3. Regulatory framework 6.10.3.4. Reimbursement scenario 6.10.3.5. UAE market estimates and forecasts, 2018 - 2030 6.10.4. Kuwait 6.10.4.1. Key country dynamics 6.10.4.2. Competitive Scenario 6.10.4.3. Regulatory framework 6.10.4.4. Reimbursement scenario 6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030 Chapter 7. Competitive Landscape 7.1. Recent Developments & Impact Analysis, By Key Market Participants 7.2. Company/Competition Categorization 7.2.1. Innovators 7.3. Vendor Landscape 7.3.1. List of key distributors and channel partners 7.3.2. Key customers 7.3.3. Key company market share analysis, 2023 7.3.4. Bioventus 7.3.4.1. Company overview 7.3.4.2. Financial performance 7.3.4.3. Product benchmarking 7.3.4.4. Strategic initiatives 7.3.5. Ectron 7.3.5.1. Company overview 7.3.5.2. Financial performance 7.3.5.3. Product benchmarking 7.3.5.4. Strategic initiatives 7.3.6. Hocoma 7.3.6.1. Company overview 7.3.6.2. Financial performance 7.3.6.3. Product benchmarking 7.3.6.4. Strategic initiatives 7.3.7. Medtronic 7.3.7.1. Company overview 7.3.7.2. Financial performance 7.3.7.3. Product benchmarking 7.3.7.4. Strategic initiatives 7.3.8. Tyromotion Inc. 7.3.8.1. Company overview 7.3.8.2. Financial performance 7.3.8.3. Product benchmarking 7.3.8.4. Strategic initiatives 7.3.9. Abbott 7.3.9.1. Company overview 7.3.9.2. Financial performance 7.3.9.3. Product benchmarking 7.3.9.4. Strategic initiatives 7.3.10. Biometrics Ltd 7.3.10.1. Company overview 7.3.10.2. Financial performance 7.3.10.3. Product benchmarking 7.3.10.4. Strategic initiatives 7.3.11. Bionik Laboratories Corp. (BNKL) 7.3.11.1. Company overview 7.3.11.2. Financial performance 7.3.11.3. Product benchmarking 7.3.11.4. Strategic initiatives 7.3.12. BioXtreme Ltd. 7.3.12.1. Company overview 7.3.12.2. Financial performance 7.3.12.3. Product benchmarking 7.3.12.4. Strategic initiatives 7.3.13. Ekso Bionics 7.3.13.1. Company overview 7.3.13.2. Financial performance 7.3.13.3. Product benchmarking 7.3.13.4. Strategic initiatives 7.3.14. Saebo, Inc 7.3.14.1. Company overview 7.3.14.2. Financial performance 7.3.14.3. Product benchmarking 7.3.14.4. Strategic initiatives 7.3.15. Kinova inc. 7.3.15.1. Company overview 7.3.15.2. Financial performance 7.3.15.3. Product benchmarking 7.3.15.4. Strategic initiatives 7.3.16. Kinestica 7.3.16.1. Company overview 7.3.16.2. Financial performance 7.3.16.3. Product benchmarking 7.3.16.4. Strategic initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
Grand View Research社の医療機器分野での最新刊レポート
本レポートと同じKEY WORD(devices)の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/22 10:26 155.52 円 163.34 円 198.56 円 |